참고문헌 (29)

1. Anonymous. Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. The American Journal of Medicine. 1993;94:646-50. 

   상세보기

2. Chung HY. Osteoporosis diagnosis and treatment 2007. Journal of Korean Endocrine Society. 2008;23:76-108. 

3. Korean Society for Bone and Mineral Research. Osteoporosis. 5th ed. Seoul:Koonja Publishing. 2016:154-233. 

4. Korean College of Rheumatology. Rheumatology. 2nd ed. Seoul:Panmuneducation. 2018:184-233. 

5. Redlich K, Smolen JS. Inflammatory bone loss: pathogenesis and therapeutic intervention. Nat Rev Drug Discov. 2012;11:234-50. 

6. Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis. Lancet. 2010;376:1094-108. 

7. Haugeberg G, Uhlig T, Falch JA, Halse JI, Kvien TK. Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: results from 394 patients in the Oslo County Rheumatoid. Arthritis Register Arthritis Rheum. 2000;43:522-30. 

8. Hauser B, Riches PL, Wilson JF, Horne AE, Ralston SH. Prevalence and clinical prediction of osteoporosis in a contemporary cohort of patients with rheumatoid arthritis. Rheumatology. 2014;53:1759-66. 

9. Wu H, Cheng K, Guo Q, Yang W, Tong L, Wang Y, Sun Z. Mapping knowledge structure and themes trends of osteoporosis in rheumatoid arthritis: a bibliometric analysis. Front Med. 2021;8:787228. 

10. Korean Society for Bone and Mineral Research. Physician's guide for osteoporosis. Seoul:Korean Society for Bone and Mineral Research Publishing. 2020:88. 

11. Cho SK, Sung YK. Treatment strategy for patients with rheumatoid arthritis. J Korean Med Assoc. 2020;63(7):422-30. 

12. Carbone LD, Kaeley G, McKown KM, Cremer M, Palmieri G, Kaplan S. Effects of long-term administration of methotrexate on bone mineral density in rheumatoid arthritis. Calcified Tissue International. 1999;64:100-1. 

    상세보기

13. Mazzantini M, Di Munno O, Incerti-Vecchi L, Pasero G. Vertebral bone mineral density changes in female rheumatoid arthritis patients treated with low-dose methotrexate. Clinical and Experimental Rheumatology. 2000;18:327-31. 

    상세보기

14. Hong SM, Lee EJ. Effects of herbal medicines on bone mineral density score in osteoporosis or osteopenia: study protocol for a systematic review and meta-analysis. J Korean Med Rehabil. 2021;31(2):49-55. 

15. Oh SJ, Ha HJ, Gu JH, Park YC, Oh MS, Jung IC, Lee EJ. The effect of herbal medicine on rheumatoid arthritis animal model: a systematic review of animal experiment studies published in Korea and overseas. J Korean Med Rehabil. 2020;30:103-16. 

16. Yoo CK, Lee YJ. A case report of oligoarticular juvenile idiopathic arthritis with oriental medication and DMARDs & NSAIDs tapering. J Pediatr Korean Med. 2013;27(4):31-8. 

17. An KS, Woo CH, Kwon OG, An HD. Therapeutic effects of Binsosan (檳蘇散) on adjuvant-induced rheumatoid rats. The Korean Journal of Oriental Medical Prescription. 2008;16(2):115-31. 

    원문보기 상세보기

18. Ouyang GL, Feng XH, Xiao LB, Huang Z, Xia Q, Zhu F. Effects of Chinese herbal medicine Qianggu capsule on patients with rheumatoid arthritis-induced osteoporosis: a report of 82 cases. Zhong Xi Yi Jie He Xue Bao. 2012;10(12):1394-9. 

19. Jin YX, Wu P, Mao YF, Wang B, Zhang JF, Chen WL, Liu Z, Shi XL. Chinese herbal medicine for osteoporosis: a meta-analysis of randomized controlled trials. Journal of Clinical Densitometry: Assessment & Management of Musculoskeletal Health. 2017;20(4):516-25. 

20. Kim SY, Park JE, Seo HJ, Lee YJ, Jang BH, Son HJ, Suh HS, Shin CM. NECA's guidance for undertaking systematic reviews and meta-analysis for intervention. 1st ed. Seoul:National Evidence-based Healthcare Collaborating Agency. 2011:24-75. 

21. WHO Study Group. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. World Health Organ Tech Rep Ser. 1994;843:1-129. 

22. Park JE, Oh DS, Choi JY, Jung SY, Kim AR, Koo CM, Jung HJ, Choi SM. Review of adverse events in acupuncture treatment. Korean Journal of Oriental Medicine. 2007;13(3):79-85. 

23. Kim HS, Dong KR, Ryu YH. Accurate quality control method of bone mineral density measurement -focus on dual energy X-ray absorptiometry-. Journal of Radiological Science and Technology. 2009;32(4):361-70. 

24. Ge J, Li SQ, Chen J, Xie LH, Xu HJ, Ma HZ. The effect of Xuling invigorating bone prescription on bone mineral density and the protein expression of OPG and RANKL in rat osteoporosis model. Chin J Osteoporos. 2016;22(5):592-5. 

25. The Society of Korean Medicine Rehabilitation. Korean medicine rehabilitation. 4th ed. Seoul:Koonja Publishing. 2015:35-134. 

26. Lim YW, Sun DH, Kim YS. Osteoporosis: pathogenesis and fracture prevention. Journal of the Korean Hip Society. 2009;21:6-16. 

    상세보기

27. Fardellone P, Salawati E, Monnier LL, Goeb V. Bone loss, osteoporosis, and fractures in patients with rheumatoid arthritis: a review. J Clin Med. 2020;9(10):3361. 

    상세보기

28. Michaud K, Wolfe F. Comorbidities in rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2007;21:885-906. 

29. Choi HJ. Treatment for osteoporosis: focusing on bisphosphonate therapy. Korean J Fam Pract. 2013;3:16-24. 

저자의 다른 논문 :

이은정 (63)